A simplified, machine-learning version of the Martin–Hopkins equation for estimating low-density lipoprotein (LDL) cholesterol has been validated in a large analysis of millions of U.S. blood samples, achieving accuracy comparable to the original clinical formula. Published in JAMA Cardiology, the work aims to make precise LDL calculation more accessible to routine laboratories, supporting better cardiovascular risk decisions.
LDL testing is central to modern preventive care, yet several commonly used estimation methods can understate LDL levels—especially when triglycerides are high. This systematic gap can delay or prevent the initiation of therapies designed to reduce the risk of heart attacks and strokes.
The study highlights the “stress test” nature of the lipid profile: low LDL coupled with elevated triglycerides is precisely where calculation errors become clinically consequential. Even differences of a few milligrams per deciliter may shift a patient’s treatment eligibility, including eligibility for potent lipid-lowering drugs such as PCSK9 inhibitors.
To develop the simplified model, researchers trained a machine-learning approach using data from 4.9 million U.S. children and adults from the Very Large Database of Lipids. The median LDL level in this representative cohort was 114 mg/dL, providing wide coverage of real-world values.
The team then compared the machine-learning equation’s LDL estimates against the original Martin–Hopkins results and against other reference approaches, including the Sampson–NIH and Friedewald equations. To evaluate performance, calculated LDL values were benchmarked against measurements obtained through ultracentrifugation, a laboratory gold standard.
Across the full dataset, the simplified model closely tracked the original equation, differing by just 0.5 mg/dL on average. In treatment-category classification, the Martin–Hopkins formulations correctly sorted 90% of samples, outperforming the competing equations, particularly for higher-risk individuals with low LDL ranges.
Validation extended beyond the initial training data: the work used more than 3.2 million samples to train the model and 1.6 million to test it, plus additional datasets—including a reference laboratory set and a clinical trial cohort from the FOURIER trial—to confirm agreement with ultracentrifugation-based measurements.
A key design goal was transparency and portability. Laboratories can implement the update by substituting the triglyceride component used in the Friedewald workflow into the Martin–Hopkins structure, enabling broad adoption without complex retooling.
The authors emphasize that the equation carries no patent restrictions and is intended to improve implementation of the forthcoming 2026 national dyslipidemia guideline, which recommends prioritizing the Martin–Hopkins calculation and setting LDL goals that vary by cardiovascular risk.
Subject of Research: People
Article Title: Development and Validation of a Simplified Martin/Hopkins Low-Density Lipoprotein Cholesterol Equation Using Machine Learning
News Publication Date: 15-Jul-2026
Web References: https://jamanetwork.com/journals/jama/fullarticle/1779534
References: FOURIER trial; Very Large Database of Lipids; ultracentrifugation-based LDL measurement
Image Credits: Not provided
Keywords: LDL cholesterol, Martin–Hopkins equation, machine learning, triglycerides, cardiovascular risk, PCSK9 inhibitors, lipid profiling, preventive cardiology
Tags: blood sample analysis for lipid profilingcardiovascular risk assessment toolsclinical decision-making in lipid managementimprovements in routine lipid testinglarge-scale validation of LDL estimation modelsLDL cholesterol calculation methodslipid profile accuracylipid-lowering therapy eligibilitymachine learning in LDL cholesterol estimationmachine learning in preventive cardiologyMartin-Hopkins LDL risk equationtriglyceride influence on LDL estimation
